Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (451-460 of 533) with videos related to

Pageof 54
Sort By:
Acta Neuropathologica Communications|November 21, 2024
High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumorsYoshiko Nakano, Ian Burns, Liana Nobre, et al.
Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.
Bulletin Du Cancer|February 5, 2026
[Pediatric neuro-oncology in French-speaking Africa: Current status and challenges]Eric Bouffet, Nacira Cherif, Ekhtelbenina Zein, et al.
Journal of Neuro-Oncology|January 18, 2017
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan diseaseJoshua Baugh, Ute Bartels, James Leach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroupsDiana M Merino, Adam Shlien, Anita Villani, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair DeficiencyAnirban Das, Uri Tabori, Lauren C Sambira Nahum, et al.
Acta Neuropathologica|October 16, 2014
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumorsJoshua Mangerel, Aryeh Price, Pedro Castelo-Branco, et al.
Cancer Discovery|February 10, 2021
Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK InhibitionBrittany B Campbell, Melissa A Galati, Simone C Stone, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Pageof 54

Showing results (451-460 of 533) with videos related to

Sort By:
Pageof 54
Acta Neuropathologica Communications|November 21, 2024
High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumorsYoshiko Nakano, Ian Burns, Liana Nobre, et al.
Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.
Bulletin Du Cancer|February 5, 2026
[Pediatric neuro-oncology in French-speaking Africa: Current status and challenges]Eric Bouffet, Nacira Cherif, Ekhtelbenina Zein, et al.
Journal of Neuro-Oncology|January 18, 2017
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan diseaseJoshua Baugh, Ute Bartels, James Leach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroupsDiana M Merino, Adam Shlien, Anita Villani, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair DeficiencyAnirban Das, Uri Tabori, Lauren C Sambira Nahum, et al.
Acta Neuropathologica|October 16, 2014
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumorsJoshua Mangerel, Aryeh Price, Pedro Castelo-Branco, et al.
Cancer Discovery|February 10, 2021
Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK InhibitionBrittany B Campbell, Melissa A Galati, Simone C Stone, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Pageof 54